Mimedx (MDXG) Gross Profit (2011 - 2026)

Mimedx's Gross Profit history runs 16 years deep, the most recent figure standing at $41.6 million for Q1 2026.

• In Q1 2026, Gross Profit fell 41.91% year-over-year to $41.6 million; the TTM figure through Mar 2026 stood at $315.6 million (up 9.3% YoY), while the FY2025 annual figure was $345.6 million, up 19.67% from the prior year.
• Gross Profit came in at $41.6 million for Q1 2026 at Mimedx, down from $99.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $99.0 million in Q4 2025 to a low of $41.6 million in Q1 2026.
• A 5-year average of $68.4 million and a median of $68.7 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit jumped 38.22% in 2025 and plunged 41.91% in 2026, its largest moves.
• Mimedx's Gross Profit stood at $60.0 million in 2022, then advanced by 21.64% to $73.0 million in 2023, then climbed by 4.12% to $76.0 million in 2024, then jumped by 30.32% to $99.0 million in 2025, then tumbled by 57.97% to $41.6 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $41.6 million, $99.0 million, and $95.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison